 Double-Blind Method
"Double-Blind Method" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment.
| Descriptor ID |
D004311
|
| MeSH Number(s) |
E05.318.780.300 E05.581.500.300 N05.715.360.780.320 N06.850.520.445.300
|
| Concept/Terms |
Double-Blind Method- Double-Blind Method
- Double Blind Method
- Double-Blind Methods
- Method, Double-Blind
- Methods, Double-Blind
- Double-Masked Method
- Double Masked Method
- Double-Masked Methods
- Method, Double-Masked
- Methods, Double-Masked
- Double-Masked Study
- Double Masked Study
- Double-Masked Studies
- Studies, Double-Masked
- Study, Double-Masked
- Double-Blind Study
- Double Blind Study
- Double-Blind Studies
- Studies, Double-Blind
- Study, Double-Blind
|
Below are MeSH descriptors whose meaning is more general than "Double-Blind Method".
Below are MeSH descriptors whose meaning is more specific than "Double-Blind Method".
This graph shows the total number of publications written about "Double-Blind Method" by people in this website by year, and whether "Double-Blind Method" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 17 | 17 | | 1997 | 0 | 17 | 17 | | 1998 | 0 | 18 | 18 | | 1999 | 0 | 19 | 19 | | 2000 | 0 | 18 | 18 | | 2001 | 0 | 23 | 23 | | 2002 | 0 | 26 | 26 | | 2003 | 1 | 28 | 29 | | 2004 | 0 | 39 | 39 | | 2005 | 0 | 36 | 36 | | 2006 | 0 | 43 | 43 | | 2007 | 0 | 34 | 34 | | 2008 | 0 | 47 | 47 | | 2009 | 0 | 50 | 50 | | 2010 | 0 | 47 | 47 | | 2011 | 0 | 55 | 55 | | 2012 | 0 | 56 | 56 | | 2013 | 0 | 57 | 57 | | 2014 | 1 | 84 | 85 | | 2015 | 0 | 72 | 72 | | 2016 | 0 | 83 | 83 | | 2017 | 0 | 79 | 79 | | 2018 | 0 | 80 | 80 | | 2019 | 0 | 83 | 83 | | 2020 | 0 | 81 | 81 | | 2021 | 0 | 69 | 69 | | 2022 | 0 | 47 | 47 | | 2023 | 0 | 51 | 51 | | 2024 | 0 | 70 | 70 | | 2025 | 0 | 101 | 101 | | 2026 | 0 | 55 | 55 |
To return to the timeline, click here.
Below are the most recent publications written about "Double-Blind Method" by people in Profiles.
-
Fontana M, Ambardekar AV, Cappelli F, Cuddy SAM, Davis MK, Garcia-Pavia P, Hanna M, Khouri MG, Masri A, Maurer MS, Obici L, Solomon S, Sperry BW, Tahara N, Waddington-Cruz M, Conrad T, Yang Q, Chen J, Tsimikas S, Gillmore JD. Baseline characteristics of patients with transthyretin amyloid cardiomyopathy in the CARDIO-TTRansform trial of eplontersen. Eur J Heart Fail. 2026 Oct 28; 28(4):807-818.
-
Rogg L, Nuñez SA, Mingrone MV, Domingo P, Rolle CP, Güerri-Fernandez R, Estrada V, Lopez M, Hanan N, Ghita GL, Jeffrey JL, Underwood M, Castillo-Mancilla JR, Halliday F, Ezeadi E, Gartland M. Proof-of-Concept Phase 2a Trial of VH4524184: An Emerging Third-Generation Integrase Strand Transfer Inhibitor With an Enhanced Resistance Profile. Clin Infect Dis. 2026 Oct 28; 83(4):e819-e825.
-
Wood RA, Togias A, Burk CM, Sindher S, Dantzer JA, Sicherer S, Wang J, Shreffler W, Kim E, Keet C, Kulis M, Jones S, Scurlock A, Leung D, Lanser B, Bird JA, Parrish C, Vickery BP, Mudd K, Long A, Ezhuthachan I, Spergel J, Brown-Whitehorn T, Ligueros-Saylan M, Iqbal A, Cameron B, Huckabee CM, Yovetich N, Rogers N, Ozanne MV, Poyser J, Veri M, Hamrah SD, Lin AA, Wheatley LM, Chinthrajah RS. Treatment of Multifood Allergy With Omalizumab or Multiallergen Oral Immunotherapy: A Randomized Clinical Trial. JAMA Pediatr. 2026 Oct 01; 180(10):1067-1075.
-
Bellido V, le Roux CW, Ekinci EI, Bjornstad P, Frias JP, Giblin K, Eyde S, Park SY, Ferro J, Johnson C, Taylor A. Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial. Lancet. 2026 Oct 10; 408(10563):1455-1472.
-
Soonhuae C, Lapierre-Nguyen S, Mariani V, Ferreira LF, Kim JS, Handberg EM, Ruzieh M, Pepine CJ, Christou DD. Vascular effects of dietary nitrate supplementation in older adults with coronary artery disease: A randomized, placebo-controlled, crossover pilot trial. Exp Gerontol. 2026 Nov; 225:113343.
-
Xiang AH, Hwang CK, Clennon E, To T, Pyrzanowski J, Calderon AB, Wilson S, Shields E, Beltran G, Sevick C, Bock M, Harris KT, Rove KO. Safety of short-term non-steroidal anti-inflammatory drug use in the postoperative setting in paediatric patients with chronic kidney disease: protocol for a randomised, placebo-controlled trial. BMJ Open. 2026 Sep 18; 16(9):e120782.
-
Le X, Passaro A, Zhao Y, Huang Y, Laskin J, Rodriguez-Abreu D, Calles A, Bazhenova L, Lo Russo G, Leighl NB, Cappuzzo F, Girard N, Popat S, Fang W, Luo Y, Li W, He Z, Zhao H, Li M, Song Q, Zhao H, El Darsa H, Monnet I, Cobo Dols M, García Campelo R, Jotte R, Berz D, Spira A, Pérol M, Nagasaka M, West H, Styles L, Li J, Clow F, Goldman J, Zhang L. Ivonescimab plus chemotherapy versus placebo plus chemotherapy in patients with advanced EGFR-mutated non-small-cell lung cancer after disease progression on EGFR tyrosine kinase inhibitor therapy (HARMONi): a multicentre, randomised, double-blind, phase 3 trial. Lancet Oncol. 2026 Sep; 27(9):1094-1109.
-
Paik WH, Huh G, Choi YH, Choi JH, Cho IR, Lee SH, Ryu JK, Kim HJ, Lee T, Park CH, Lee Y, Cho SH, Seo DW, Lee KH, Lee KT, Lee JK, Jang S, Vargo J, Edmundowicz S, Park JK, Park DH. Acetate- Versus Lactate-Buffered Crystalloids for Prevention of Post-ERCP Pancreatitis in Patients Without Access to Rectal NSAIDs: A Multicentre Double-Blind Randomized Trial. United European Gastroenterol J. 2026 Sep; 14(7):e70281.
-
Mitchell JJ, Abdenur JE, de Boer F, Boyer M, Breilyn MS, Couce ML, De Leon DD, Derks TG, El-Gharbawy A, Haijer-Schreuder AB, Loechner K, Longo N, Lund AM, Olmos MAM, McCandless SE, de Oliveira BM, Mount M, Muschol N, Pytlak K, Radhakrishnan K, Riba-Wolman R, Rodriguez-Buritica DF, La Rosa A, Rossi A, Saavedra H, Santer R, Shayota B, Smit GPA, Moura De Souza CF, van der Klauw MM, Weinstein DA, Wolfsdorf JI, Blake A, Grimm AA, Mitragotri D, Rahman S, Turner-Bowker DM, Collis R. Phase 3 Randomized Trial Results of DTX401 AAV Gene Therapy for the Treatment of GSDIa. J Inherit Metab Dis. 2026 Sep; 49(5):e70241.
-
Paganoni S, Chibnik LB, Quintana M, Macklin EA, Detry MA, Vestrucci M, Paulon G, McGlothlin A, Wang J, Walk D, Elman L, Chase M, Heyd L, Harkey B, Sherman AV, Shefner J, Berry JD, Scirocco E, Giacomelli E, Yu H, Kittle G, Hall M, Ho D, Jawdat O, Ladha S, Locatelli E, Rivner M, Felice K, Katz J, Ajroud-Driss S, Fee D, Miller T, Rosow L, Quick A, Heitzman D, Foster LA, Maragakis NJ, Goutman SA, Rosenfeld J, Benatar M, Swenson A, Connors RD, Shroff S, Bedlack R, McIlduff CE, Chen IA, Fernandes JAM, Walsh A, Peltier A, Ilieva H, Diaz F, Kushlaf H, Beydoun SR, Myers B, Arcila-Londono X, Heiman-Patterson T, Elliott M, Whitesell J, Al-Lahham T, Elliott M, Olney N, Baer M, Jackson C, Young E, Caress J, Weiss MD, Kuenzler R, Nayar S, Kasarskis EJ, Simmons Z, Gibson S, Owegi MA, Goyal NA, Wymer JP, Gwathmey KG, Erickson A, Gursoy N, Alameda G, Bodkin C, Wu A, Martinez-Thompson J, Twydell PT, Andrews J, Bayat E, Rezania K, Usman U, McCluskey L, Kovvuru S, Jennings D, Garza-Meilandt A, Maciuca R, Cohen IV, Tamuly D, Eren E, Cudkowicz ME, Babu S. DNL343 and Disease Progression in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial. JAMA Netw Open. 2026 Sep 01; 9(9):e2634809.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|